Efficacy of 4 Years of Octreotide Long-Acting Release Therapy in Patients With Severe Polycystic Liver Disease

Những quyển sách tương tự

• Pansomatostatin Agonist Pasireotide Long-Acting Release for Patients with Autosomal Dominant Polycystic Kidney or Liver Disease with Severe Liver Involvement: A Randomized Clinical Trial
  Bằng: Hogan, Marie C., et al.
  Được phát hành: (2020)
• Randomized Clinical Trial of Long-Acting Somatostatin for Autosomal Dominant Polycystic Kidney and Liver Disease
  Bằng: Hogan, Marie C., et al.
  Được phát hành: (2010)
• Somatostatin analog therapy for severe polycystic liver disease: results after 2 years
  Bằng: Hogan, Marie C., et al.
  Được phát hành: (2012)
• Pasireotide is more effective than Octreotide in reducing hepato-renal cystogenesis in rodents with polycystic kidney and liver diseases
  Bằng: Masyuk, Tatyana V, et al.
  Được phát hành: (2013)
• Polycystic Liver Disease: The benefits of targeting cAMP
  Bằng: Masyuk, Tatyana V, et al.
  Được phát hành: (2016)